Clinical outcomes of ileostomy closure according to timing during adjuvant chemotherapy after rectal cancer surgery

Yoo Jin Choi, Jung Myun Kwak, Neul Ha, Tae Hoon Lee, Se Jin Baek, Jin Kim, Seon Hahn Kim

Research output: Contribution to journalArticle

Abstract

Purpose: No guidelines exist detailing when to implement a temporary ileostomy closure in the setting of adjuvant chemotherapy following sphincter-saving surgery for rectal cancer. The aim of this study was to evaluate the clinical and oncological outcomes of ileostomy closure during adjuvant chemotherapy in patients with curative resection of rectal cancer. Methods: This retrospective study investigated 220 patients with rectal cancer undergoing sphincter-saving surgery with protective loop ileostomy from January 2007 to August 2016. Patients were divided into 2 groups: group 1 (n = 161) who underwent stoma closure during adjuvant chemotherapy and group 2 (n = 59) who underwent stoma closure after adjuvant chemotherapy. Results: No significant differences were observed in operative time, blood loss, postoperative hospital stay, or postoperative complications in ileostomy closure between the 2 groups. No difference in overall survival (P = 0.959) or disease-free survival (P = 0.114) was observed between the 2 groups. Conclusion: Ileostomy closure during adjuvant chemotherapy was clinically safe, and interruption of chemotherapy due to ileostomy closure did not change oncologic outcomes.

Original languageEnglish
Pages (from-to)187-193
Number of pages7
JournalAnnals of Coloproctology
Volume35
Issue number4
DOIs
Publication statusPublished - 2019 Jan 1

Keywords

  • Adjuvant chemotherapy
  • Ileostomy
  • Rectal neoplasms

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Clinical outcomes of ileostomy closure according to timing during adjuvant chemotherapy after rectal cancer surgery. / Choi, Yoo Jin; Kwak, Jung Myun; Ha, Neul; Lee, Tae Hoon; Baek, Se Jin; Kim, Jin; Kim, Seon Hahn.

In: Annals of Coloproctology, Vol. 35, No. 4, 01.01.2019, p. 187-193.

Research output: Contribution to journalArticle

@article{7a7fb784d3124d0e8cb579890b1deae4,
title = "Clinical outcomes of ileostomy closure according to timing during adjuvant chemotherapy after rectal cancer surgery",
abstract = "Purpose: No guidelines exist detailing when to implement a temporary ileostomy closure in the setting of adjuvant chemotherapy following sphincter-saving surgery for rectal cancer. The aim of this study was to evaluate the clinical and oncological outcomes of ileostomy closure during adjuvant chemotherapy in patients with curative resection of rectal cancer. Methods: This retrospective study investigated 220 patients with rectal cancer undergoing sphincter-saving surgery with protective loop ileostomy from January 2007 to August 2016. Patients were divided into 2 groups: group 1 (n = 161) who underwent stoma closure during adjuvant chemotherapy and group 2 (n = 59) who underwent stoma closure after adjuvant chemotherapy. Results: No significant differences were observed in operative time, blood loss, postoperative hospital stay, or postoperative complications in ileostomy closure between the 2 groups. No difference in overall survival (P = 0.959) or disease-free survival (P = 0.114) was observed between the 2 groups. Conclusion: Ileostomy closure during adjuvant chemotherapy was clinically safe, and interruption of chemotherapy due to ileostomy closure did not change oncologic outcomes.",
keywords = "Adjuvant chemotherapy, Ileostomy, Rectal neoplasms",
author = "Choi, {Yoo Jin} and Kwak, {Jung Myun} and Neul Ha and Lee, {Tae Hoon} and Baek, {Se Jin} and Jin Kim and Kim, {Seon Hahn}",
year = "2019",
month = "1",
day = "1",
doi = "10.3393/ac.2018.10.18.1",
language = "English",
volume = "35",
pages = "187--193",
journal = "Annals of Coloproctology",
issn = "2287-9714",
publisher = "Korean Society of Coloproctology",
number = "4",

}

TY - JOUR

T1 - Clinical outcomes of ileostomy closure according to timing during adjuvant chemotherapy after rectal cancer surgery

AU - Choi, Yoo Jin

AU - Kwak, Jung Myun

AU - Ha, Neul

AU - Lee, Tae Hoon

AU - Baek, Se Jin

AU - Kim, Jin

AU - Kim, Seon Hahn

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: No guidelines exist detailing when to implement a temporary ileostomy closure in the setting of adjuvant chemotherapy following sphincter-saving surgery for rectal cancer. The aim of this study was to evaluate the clinical and oncological outcomes of ileostomy closure during adjuvant chemotherapy in patients with curative resection of rectal cancer. Methods: This retrospective study investigated 220 patients with rectal cancer undergoing sphincter-saving surgery with protective loop ileostomy from January 2007 to August 2016. Patients were divided into 2 groups: group 1 (n = 161) who underwent stoma closure during adjuvant chemotherapy and group 2 (n = 59) who underwent stoma closure after adjuvant chemotherapy. Results: No significant differences were observed in operative time, blood loss, postoperative hospital stay, or postoperative complications in ileostomy closure between the 2 groups. No difference in overall survival (P = 0.959) or disease-free survival (P = 0.114) was observed between the 2 groups. Conclusion: Ileostomy closure during adjuvant chemotherapy was clinically safe, and interruption of chemotherapy due to ileostomy closure did not change oncologic outcomes.

AB - Purpose: No guidelines exist detailing when to implement a temporary ileostomy closure in the setting of adjuvant chemotherapy following sphincter-saving surgery for rectal cancer. The aim of this study was to evaluate the clinical and oncological outcomes of ileostomy closure during adjuvant chemotherapy in patients with curative resection of rectal cancer. Methods: This retrospective study investigated 220 patients with rectal cancer undergoing sphincter-saving surgery with protective loop ileostomy from January 2007 to August 2016. Patients were divided into 2 groups: group 1 (n = 161) who underwent stoma closure during adjuvant chemotherapy and group 2 (n = 59) who underwent stoma closure after adjuvant chemotherapy. Results: No significant differences were observed in operative time, blood loss, postoperative hospital stay, or postoperative complications in ileostomy closure between the 2 groups. No difference in overall survival (P = 0.959) or disease-free survival (P = 0.114) was observed between the 2 groups. Conclusion: Ileostomy closure during adjuvant chemotherapy was clinically safe, and interruption of chemotherapy due to ileostomy closure did not change oncologic outcomes.

KW - Adjuvant chemotherapy

KW - Ileostomy

KW - Rectal neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85073393084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073393084&partnerID=8YFLogxK

U2 - 10.3393/ac.2018.10.18.1

DO - 10.3393/ac.2018.10.18.1

M3 - Article

AN - SCOPUS:85073393084

VL - 35

SP - 187

EP - 193

JO - Annals of Coloproctology

JF - Annals of Coloproctology

SN - 2287-9714

IS - 4

ER -